#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Toxic epidermal necrolysis Mantle cell lymphoma refractory Autoimmune haemolytic anaemia Congenital megacolon Immune thrombocytopenia Porphyria non-acute Infection in an immunocompromised host Oesophageal atresia Cholestatic pruritus Chorioretinitis Mycobacterium abscessus infection Atypical haemolytic uraemic syndrome Cholangiosarcoma Chronic graft versus host disease Myelofibrosis More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Treatment Cholangitis sclerosing – Treatment Medulloblastoma – Trials in Disease Mucopolysaccharidosis I – Diagnostics Adrenogenital syndrome – Life with Disease Antisynthetase syndrome – Life with Disease Hairy cell leukaemia recurrent Lymphatic malformation – Diagnostics Malignant fibrous histiocytoma – Trials in Disease Mantle cell lymphoma stage II – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carboplatin Tetracosactide TRIACYLGLYCEROL LIPASE ADCE-D01 Levobupivacaine Hydrochloride Pilocarpine Nitrate Lidocaine APAZUNERSEN Paclitaxel Tulmimetostat Candesartan Cilexetil Batoprotafib Chlorhexidine Dihydrochloride Digoxin Microcrystalline Cellulose Hydroxycarbamide Midostaurin Propylene Glycol Evencaleucel Allogeneic Faecal Microbiota More therapies…

    Learn about Your Condition

    Cancer pain Rhabdoid tumour Mitral valve incompetence Pleural mesothelioma Haemorrhagic stroke Senile dementia Vasospasm Spinal cord injury cervical Periarthritis Arthralgia Small cell carcinoma Neuropathy peripheral Myotonia Exposure via breast milk Palpitations More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of avelumab and cetuximab combination treatment after TPEx chemotherapy for patients with recurrent or metastatic head and neck cancer receiving first-line therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Avelumab
    • Carboplatin
    • Cetuximab
    France

  • A study comparing medium-chain triglycerides and sodium chloride infusions during hemodialysis to improve toxin removal in patients with chronic kidney disease

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Soya Oil
    • Triglycerides, Medium Chain
    • Sodium Chloride
    France

  • Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Fludarabine Phosphate
    • Mitoxantrone
    • Daunorubicin Hydrochloride
    Belgium Denmark Finland The Netherlands Norway Spain +1

  • Study on Steroid and Rivaroxaban Treatment for Deep Vein Thrombosis in Behçet’s Syndrome Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Behcet’s syndrome
    Investigated Drugs:
    • Rivaroxaban
    France

  • Study on the Safety and Effectiveness of ProTrans for Treating Type 1 Diabetes in Children and Adolescents

    Recruiting

    2 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Protrans
    Sweden

  • Study of ABTL0812, Irinotecan, and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neuroblastoma
    • Neoplasm
    Investigated Drugs:
    • Sodium 2-Hydroxylinoleate
    • Irinotecan
    • Temozolomide
    Spain
Previous Page
1 … 416 417 418 419 420 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!